Bedrocan & SyqeAir: Consistent Therapeutic Effect with Medicinal Cannabis
Bedrocan is a world-renowned producer of pharmaceutical-grade medicinal cannabis based in the Netherlands and certified by the European Union’s guidelines for Good Manufacturing Practice (EU-GMP). With almost four decades of expertise in the indoor cultivation of plants under standardized and controlled conditions, Bedrocan has become a leading innovator in the development of standardized, quality-controlled, whole-flower cannabis.
Standardization: The Key to Consistent Therapeutic Effect
The medicinal properties of cannabis have been known for centuries, yet, it is not a medicine.
Standardization in cannabis means that not only the THC and CBD content in the flower should be stable from one batch to another but also that over 400 potential active components (cannabinoids, terpenes, and more) would be balanced from batch to batch.
Standardization also enables the comparison of findings from different clinical trials and studies across time. It is a critical factor for creating an evidence infrastructure for the effectiveness of medicinal cannabis.
Standardization is crucial when it comes to providing stable treatment with medicinal cannabis, as it is the only method optimizing the consistent therapeutic effect that physicians and patients can achieve over time. It helps maximize the reproducibility of the dose and the dosage composition (i.e., can be repeated again and again) and enables patients and healthcare professionals to better adjust a personal and optimal dose by titration (a gradual dosage adjustment process). This allows for proper monitoring the medicinal cannabis treatment’s effectiveness, safety, and potential side effects.
Achieving the Highest Quality Using Advanced Cultivation Technology
Bedrocan was the first to produce medicinal cannabis according to the European Union’s good manufacturing practice standards (EU-GMP). Their production facilities and practices follow the highest quality standards throughout the entire production process, from plant genetics to the finished product.
Bedrocan operates multiple indoor cultivation facilities that use state-of-the-art environmental control technologies to control all variables, including light, temperature, nutrients, and water. Each of these rooms is sealed with special doors to prevent contact with airborne contaminants. The company’s production process has been specifically refined to grow standardized cannabis plants without the use of any pesticides. Every batch is also individually sampled and checked for the presence of heavy metals.
All these qualities ensure that Bedrocan produces medicinal cannabis of the highest quality to provide patients and healthcare professionals with reliable products.
Reasons for choosing the Bedrocan® product for the SyqeAir Cartridges
The product we chose to use and put inside our SyqeAir Cartridges is Bedrocan® – Cannabis sativa L. ‘Afina’ flos. It’s the most widely used medicinal cannabis product in research compared to other cannabis products.
Read more>>
Apart from the Bedrocan® product, the company produces four other products for medicine development and clinical use: Bedrobinol®, Bediol®, Bedica®, and Bedrolite®. All of Bedrocan’s products are standardized according to pharmaceutical standards with a defined active ingredient composition.
Combining a unique standardized and clinically-researched cannabis product with the breakthrough SyqeAir Metered-Dose Inhaler enables us to provide patients with safe and effective treatment using medicinal cannabis. The SyqeAir Inhaler delivers low and consistent doses of medicinal cannabis via inhalation to reduce the intensity of chronic neuropathic pain with minimum psychoactive adverse effects (compared to the other routes of administration) to establish an optimal daily routine and improve the quality of life of the patients.
Tour of Bedrocan:
© Bedrocan corporate video
© Photos from Bedrocan archive
References:
Bedrocan.com
